| Trial ID: | L0272 |
| Source ID: | NCT03744182
|
| Associated Drug: |
HM15211
|
| Title: |
A Study of Multiple Doses of HM15211 in Obese Subjects With NAFLD
|
| Acronym: |
--
|
| Status: |
Completed
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
NAFLD
|
| Interventions: |
Drug: HM15211|Drug: Placebo of HM15211
|
| Outcome Measures: |
Adverse Events|Clinical lab abnormalities|Physical examination|Vital signs|12-lead ECG
|
| Sponsor/Collaborators: |
Hanmi Pharmaceutical Company Limited
|
| Gender: |
All
|
| Age: |
18 Years to 65 Years ?? (Adult, Older Adult)
|
| Phases: |
Phase 1
|
| Enrollment: |
66
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment
|
| Start Date: |
November 1, 2018
|
| Completion Date: |
March 18, 2020
|
| Results First Posted: |
--
|
| Last Update Posted: |
September 29, 2021
|
| Locations: |
ProSciento Inc., Chula Vista, California, United States
|
| URL: |
https://ClinicalTrials.gov/show/NCT03744182
|
